TABLE 1.
Characteristic | Category | Number | Percentage |
---|---|---|---|
Source register | ANZCTR | 1 | 1.82 |
Clinicaltrials.gov | 24 | 43.64 | |
ChiCTR | 8 | 14.55 | |
CTRI | 4 | 7.27 | |
ISRCTN | 2 | 3.64 | |
JPRN | 11 | 20.00 | |
German clinical trial register | 5 | 9.09 | |
Recruitment status | Not recruiting | 35 | 63.64 |
Recruiting | 20 | 36.36 | |
Target size | ≦50 | 27 | 49.09 |
51–100 | 10 | 18.18 | |
101–200 | 9 | 16.36 | |
201–500 | 4 | 7.27 | |
501–1,000 | 3 | 5.45 | |
1,001–10,000 | 2 | 3.64 | |
In vitro/in vivo | In vitro | 31 | 56.36 |
In vivo | 24 | 43.64 | |
Evaluation factors | Single | 8 | 14.55 |
Multiple (image and fingerprint) | 47 | 85.45 | |
Study type | Observational | 30 | 54.55 |
Diagnostic test | 5 | 9.09 | |
Interventional | 18 | 32.73 | |
Relative factors research | 1 | 1.82 | |
Meta-analysis | 1 | 1.82 | |
Phase | Phase 1 | 1 | 1.82 |
Phase 2 | 3 | 5.45 | |
Phase 3 | 1 | 1.82 | |
Post-market | 1 | 1.82 | |
Not applicable | 47 | 85.45 | |
Diagnostic new technique clinical study | 2 | 3.64 |